Roman Stillhard
Gastroenterologie | Hepatologie · Dept. I
MSD MK1308A-004
03.07.2021Phase 2, Multicenter, Clinical Study to Evaluate the Safety and Efficacy of MK-1308A (Coformulated MK-1308/MK-3475) in Combination with Lenvatinib (E7080/MK-7902) in First-line Therapy of Participants with Advanced Hepatocellular Carcinoma
Klinische Forschung - 03.07.2021 - 03.12.2022
Automatisch geschlossen
Projektleitung: Semela David
Mitarbeiter/innen: Stillhard Roman, Bergamin Irina
ESSENCE Study
01.08.2020
Klinische Forschung - 01.08.2020 - 31.12.2029
Laufend
Projektleitung: Bilz Stefan
Mitarbeiter/innen: Semela David, Räss Andrea, Stillhard Roman
COSMIC 312
01.09.2019A Randomized, Controlled Phase 3 Study of Cabozantinib (XL184) in Combination with Atezolizumab versus Sorafenib in Subjects with Advanced Hepatocellular Carcinoma Who Have Not Received Previous Systemic Anticancer Therapy Randomisation 2:1:1:1 Cabo...
Klinische Forschung - 01.09.2019 - 28.11.2020
Abgeschlossen
Projektleitung: Semela David
Mitarbeiter/innen: Stillhard Roman
MSD-MK-3475 KEYNOTE 937
01.05.2019A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) versus Placebo as Adjuvant herapy in Participants ith Hepatocellular Carcinoma and Complete Radiological Response after Surgical esection or Local...
Klinische Forschung - 01.05.2019 - 01.05.2026
Laufend
Projektleitung: Semela David
Mitarbeiter/innen: Stillhard Roman
A prospective randomized, parallel-group, multicentre, superiority trial of the SUPERA peripheral stent system in patients with femoro-popliteal artery disease
01.01.2019The primary objective of the study is to investigate, if the Supera® Peripheral Stent System has clinical superiority over EverFlex™ Self-Expanding Peripheral Stent System with Entrust™ Delivery System or as Protégé™ EverFlex™, a standard self-expand...
Klinische Forschung - 01.01.2019 - 31.12.2025
Laufend
Projektleitung: Hechelhammer Lukas
Mitarbeiter/innen: Dick Florian, von Allmen Regula, Benecke Ulf, Baumer Andrea, Koeger Philipp, Stillhard Roman
ACRE
01.01.2018A MULTICENTER, MULTI-NATIONAL, RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, PHASE IIA STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF AN ANTHOCYANIN RICH EXTRACT (ACRE) IN PATIENTS WITH ULCERATIVE COLITIS.
Klinische Forschung - 01.01.2018 - 01.07.2021
Abgeschlossen
Projektleitung: Brand Stephan
Mitarbeiter/innen: Stillhard Roman, Sulz Michael, Krieger-Grübel Claudia, Smolders Jolijn
ICL670, Deferasirox
01.08.2017A phase II, multicenter, open-label, randomized two-year study to evaluate the efficacy and safety of deferasirox film-coated tablet versus phlebotomy in patients with Hereditary Hemochromatosis
Klinische Forschung - 01.08.2017 - 01.01.2020
Abgeschlossen
Projektleitung: Semela David
Mitarbeiter/innen: Stillhard Roman
GFT505-315
01.03.2017A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis
Klinische Forschung - 01.03.2017 - 01.11.2020
Abgebrochen
Mitarbeiter/innen: Stillhard Roman, Semela David
HEMATITE
16.12.2016Quality of Life measurement using wrist actigraph in HCV genotype 1 infected, Treatment naive patients suffering from fatique and receiving Viekirax/Exviera.
Klinische Forschung - 16.12.2016 - 16.12.2018
Abgeschlossen
Projektleitung: Semela David
Mitarbeiter/innen: Stillhard Roman
SASL 38 Swiss Cohort Study on Autoimmun Hepatitis
14.09.2016Research project in which biological material is sampled from humans and health-related personal data is collected for research.
Klinische Forschung - 14.09.2016 - 14.09.2022
Automatisch geschlossen
Projektleitung: Semela David
Mitarbeiter/innen: Stillhard Roman
SASL 39 Swiss Cohort Study on Primary Biliary Cholangitis
14.09.2016Research project in which biological material is sampled from humans and health-related personal data is collected for research.
Klinische Forschung - 14.09.2016 - 14.09.2022
Automatisch geschlossen
Projektleitung: Semela David
Mitarbeiter/innen: Stillhard Roman
SASL 40 Swiss Cohort Study on Primar Sclerosing Cholangitis
01.06.2016Research project in which biological material is sampled from humans and health-related personal data is collected for research.
Klinische Forschung - 01.06.2016 - 14.09.2022
Automatisch geschlossen
Projektleitung: Semela David
Mitarbeiter/innen: Stillhard Roman
Abbvie M14-423 An Open Label, Multicenter Study to Evaluate Long-Term Outcomes With ABT-450/Ritonavir/ABT-267 and ABT-333 With or Without Ribavirin in Adults With Genotyp 1 Chronic Hepatitis C Infection
26.03.2015
Klinische Forschung - 26.03.2015 - 31.03.2020
Automatisch geschlossen
Projektleitung: Semela David
Mitarbeiter/innen: Bernsmeier Christine, Künzler-Heule Patrizia, Stillhard Roman
Liver Function Assessment after Placement of a Transjugular Intrahepatic Portosystemic Shunt (TIPS) a Monocenter, prospective interventional study
16.11.2013Monocenter, prospective interventional study Patients scheduled for TIPS placement will undergo testing before and after TIPS placement: LiMAx, Stroop test, CTT, MMS, GCS, clinical assessment, laboratory testing (creatinin, bilirubin, INR, albumin, h...
Klinische Forschung - 16.11.2013 - 16.04.2019
Abgeschlossen
Projektleitung: Semela David
Mitarbeiter/innen: Stillhard Roman, Künzler-Heule Patrizia, Sawatzki Mikael, Semadeni Gian-Marco, Sulz Michael, Hechelhammer Lukas